Suggestions
Harish Soundararajan
Managing Director at Marshall Wace
Professional Background
Harish Soundararajan is a distinguished professional in the intersection of bioengineering and finance, boasting a rich career trajectory that combines extensive research experience with strategic investment management. As a former Engagement Manager at McKinsey & Company, he demonstrated his ability to tackle complex challenges and deliver innovative solutions in the life sciences sector. Leveraging his analytical prowess and deep understanding of biological sciences, he transitioned into the world of finance, where he served as an Investment Director at Farallon Capital Management. In this role, he spearheaded investments in cutting-edge biotechnologies and played a crucial part in portfolio management.
During his tenure at Farallon Capital Management, Harish had the opportunity to lead investments in several pioneering companies that are driving advances in medical technologies and therapeutics. This includes significant roles as Lead Investor and Member of the Board of Directors at notable firms such as Metagenomi, InBrace, LUMICKS, and Imago BioSciences, Inc. His strategic vision has directly contributed to the growth and success of these companies, further solidifying his reputation as a key figure in the venture investment community.
Education and Achievements
Harish Soundararajan's academic journey is marked by prestigious institutions and rigorous training. He commenced his academic path by earning a Bachelor of Engineering (BE) in Electrical Engineering from Anna University, where he laid a strong foundation in engineering principles that would later inform his work in bioengineering. Driven by a passion for understanding complex biological systems, he pursued a Doctor of Philosophy (Ph.D.) in Biological Sciences from Trinity College at the University of Cambridge. Here, he engaged in groundbreaking research that expanded the frontiers of the biological sciences.
He further advanced his expertise by becoming a Postdoctoral Fellow in Bioengineering and Biomedical Engineering at Harvard Medical School. During this postdoctoral tenure, Harish investigated new methodologies at the Wyss Institute for Biologically Inspired Engineering, where he contributed to transformative research projects focusing on bioengineering innovations.
Harish’s educational background equips him with a unique blend of technical insights and analytical skills, allowing him to succeed in both academic research and real-world application within the life sciences industry.
Notable Projects and Contributions
Over the years, Harish has played a pivotal role in various life science ventures, with a strong focus on biotechnology and therapeutic innovations. As a Lead Investor and Board Director at Themis Bioscience GmbH, he has been at the forefront of investing in vaccine development and cutting-edge immunotherapy research. His impact extends to leading investment efforts at companies such as VelosBio and Inivata, where he contributed to the commercialization of groundbreaking cancer diagnostics.
Through a combination of his analytical skills honed at McKinsey & Company and his deep scientific knowledge from his years in the laboratory, Harish has made remarkable strides in guiding early-stage companies toward achieving their growth potential. His involvement with UNIVERCELLS S.A. and Asymmetric Technologies showcases his commitment to applying advanced technologies that address global healthcare challenges.
Community Engagement and Future Goals
Beyond his impressive career in investments and science, Harish is deeply committed to community engagement and the advancement of the biotechnology field. He actively seeks to mentor young professionals and entrepreneurs, empowering the next generation of innovators. Harish believes in the importance of fostering a collaborative environment where knowledge is shared, and groundbreaking ideas can flourish.
Looking to the future, Harish Soundararajan aims to continue his journey in scalable biotechnology solutions that address pressing global health issues. He envisions a landscape where biotechnologies are more widely accessible and integrated into traditional healthcare systems, aiding in the fight against diseases and improving overall patient outcomes.
Achievements
- Postdoctoral Fellow at Harvard Medical School in Bioengineering and Biomedical Engineering
- Ph.D. in Biological Sciences from Trinity College, University of Cambridge
- B.E. in Electrical Engineering from Anna University
- Strategic leadership in investing at Farallon Capital Management
- Key investments as a Lead Investor in multiple noteworthy biotechnology companies.
